Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1995 Nov;222(5):609–611. doi: 10.1097/00000658-199311000-00001

Preoperative chemotherapy: where do we go from here?

T J Eberlein
PMCID: PMC1234986  PMID: 7487206

Full text

PDF
609

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonadonna G., Veronesi U., Brambilla C., Ferrari L., Luini A., Greco M., Bartoli C., Coopmans de Yoldi G., Zucali R., Rilke F. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst. 1990 Oct 3;82(19):1539–1545. doi: 10.1093/jnci/82.19.1539. [DOI] [PubMed] [Google Scholar]
  2. Eberlein T. J., Connolly J. L., Schnitt S. J., Recht A., Osteen R. T., Harris J. R. Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. Arch Surg. 1990 Jun;125(6):771–777. doi: 10.1001/archsurg.1990.01410180097016. [DOI] [PubMed] [Google Scholar]
  3. Fisher B., Bauer M., Margolese R., Poisson R., Pilch Y., Redmond C., Fisher E., Wolmark N., Deutsch M., Montague E. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985 Mar 14;312(11):665–673. doi: 10.1056/NEJM198503143121101. [DOI] [PubMed] [Google Scholar]
  4. Hortobagyi G. N., Blumenschein G. R., Spanos W., Montague E. D., Buzdar A. U., Yap H. Y., Schell F. Multimodal treatment of locoregionally advanced breast cancer. Cancer. 1983 Mar 1;51(5):763–768. doi: 10.1002/1097-0142(19830301)51:5<763::aid-cncr2820510502>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  5. Jacquillat C., Baillet F., Weil M., Auclerc G., Housset M., Auclerc M., Sellami M., Jindani A., Thill L., Soubrane C. Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB). Cancer. 1988 May 15;61(10):1977–1982. doi: 10.1002/1097-0142(19880515)61:10<1977::aid-cncr2820611008>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  6. Peoples G. E., Goedegebuure P. S., Smith R., Linehan D. C., Yoshino I., Eberlein T. J. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):432–436. doi: 10.1073/pnas.92.2.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Powles T. J., Hickish T. F., Makris A., Ashley S. E., O'Brien M. E., Tidy V. A., Casey S., Nash A. G., Sacks N., Cosgrove D. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol. 1995 Mar;13(3):547–552. doi: 10.1200/JCO.1995.13.3.547. [DOI] [PubMed] [Google Scholar]
  8. Smith I. E., Jones A. L., O'Brien M. E., McKinna J. A., Sacks N., Baum M. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. Eur J Cancer. 1993;29A(12):1796–1799. doi: 10.1016/0959-8049(93)90133-z. [DOI] [PubMed] [Google Scholar]
  9. Veronesi U., Bonadonna G., Zurrida S., Galimberti V., Greco M., Brambilla C., Luini A., Andreola S., Rilke F., Raselli R. Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg. 1995 Nov;222(5):612–618. doi: 10.1097/00000658-199511000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES